QUICK SEARCH:   [advanced]
Author:
Keyword(s):
Year:  Vol:  Page: 

   

 

Health Affairs, 24, no. 3 (2005): 780-789
doi: 10.1377/hlthaff.24.3.780
© 2005 by Project HOPE
 
New Online
 * Senate Health Reform Bill
 * Rewarding Providers
 * Public Option Policy Brief
 * Health Reform & Abortion
 * Delivery System Reform
This Article
* Full Text (HTML)
* Reprint (PDF)
* Submit a response to this article
* Alert me when this article is cited
* Alert me when Comments are posted
* Alert me if a correction is posted
Services
* E-mail this article to a friend
* Similar articles in this journal
* Similar articles in Web of Science
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Personal Archive
* Download to Citation Manager
*Reprints & Permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Web of Science (18)
* Citing Articles via Google Scholar
Google Scholar
* Articles by Cunningham, P. J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Cunningham, P. J.
Related Collections
* Access To Care
* Managed Care - Medicaid
* Medicaid
* Pharmaceuticals
* State/Local Issues
* Health Spending
* Consumer Issues

Health Tracking

MARKETWATCH

Medicaid Cost Containment And Access To Prescription Drugs

Peter J. Cunningham

States have been intensifying their efforts to control rising prescription drug costs in their Medicaid programs. This study examines the effects of five Medicaid cost containment policies on enrollees’ perceptions of their ability to get prescription drugs. The results show that enrollees in states that have implemented all or almost all of these five policies have greater problems getting prescription drugs than enrollees in other states encounter. In terms of specific policies, prior authorization and mandatory generic substitutions had the largest effects on access to prescription drugs.


Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati    What's this?


This article has been cited by other articles:


Home page
Psychiatr. Serv.Home page
J. C. West, J. E. Wilk, D. S. Rae, I. S. Muszynski, M. R. Stipec, C. L. Alter, K. E. Sanders, S. Crystal, and D. A. Regier
Medicaid Prescription Drug Policies and Medication Access and Continuity: Findings From Ten States
Psychiatr Serv, May 1, 2009; 60(5): 601 - 610.
[Abstract] [Full Text] [PDF]


Home page
AJPHHome page
T. J. Johnson and S. Stahl-Moncada
Medicaid Prescription Formulary Restrictions and Arthritis Treatment Costs
Am J Public Health, July 1, 2008; 98(7): 1300 - 1305.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
D. P. Goldman, G. F. Joyce, and Y. Zheng
Prescription Drug Cost Sharing: Associations With Medication and Medical Utilization and Spending and Health
JAMA, July 4, 2007; 298(1): 61 - 69.
[Abstract] [Full Text] [PDF]


Home page
Health Aff (Millwood)Home page
J. M. Polinski, P. S. Wang, and M. A. Fischer
Medicaid's Prior Authorization Program And Access To Atypical Antipsychotic Medications
Health Aff., May 1, 2007; 26(3): 750 - 760.
[Abstract] [Full Text] [PDF]


Home page
Health Aff (Millwood)Home page
C. Smith, C. Cowan, S. Heffler, A. Catlin, and the National Health Accounts Team
National Health Spending In 2004: Recent Slowdown Led By Prescription Drug Spending
Health Aff., January 1, 2006; 25(1): 186 - 196.
[Abstract] [Full Text] [PDF]



Home | Current Issue | Archives | Topic Collections | Search | Blog | Subscribe | Contact Us | Help

© 2001-2005 Project HOPE–The People-to-People Organization
Terms and Policies